Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.

Karibe A, Tobacman LS, Strand J, Butters C, Back N, Bachinski LL, Arai AE, Ortiz A, Roberts R, Homsher E, Fananapazir L.

Circulation. 2001 Jan 2;103(1):65-71.

2.

Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.

Marian AJ, Roberts R.

Ann Med. 1998 Aug;30 Suppl 1:24-32. Review.

PMID:
9800880
3.

[Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].

Sadoul N, de Chillou C, Aliot E, McKenna WJ.

Arch Mal Coeur Vaiss. 1999 Apr;92 Spec No 1:65-73. Review. French.

PMID:
10326160
4.

Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.

Jääskeläinen P, Miettinen R, Kärkkäinen P, Toivonen L, Laakso M, Kuusisto J.

Ann Med. 2004;36(1):23-32. Review.

PMID:
15000344
5.

[Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].

Ramírez CD, Padrón R.

Invest Clin. 2004 Mar;45(1):69-99. Review. Spanish.

PMID:
15058760
6.

[Genetic changes and clinical management in familial hypertrophic cardiomyopathy].

Domal-Kwiatkowska D, Smolik S, Mazurek U, Moric E, Polońska J, Nowalany-Kozielska E, Glanowska G, Wodniecki J, Szarek J, Wilczewski P, Kozakiewicz K, Tendera M, Wilczok T.

Wiad Lek. 2000;53(1-2):4-21. Review. Polish.

PMID:
10806915
7.

The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.

Sorajja P, Elliott PM, McKenna WJ.

Europace. 2000 Jan;2(1):4-14. Review. No abstract available.

PMID:
11225594
8.

Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.

Redwood CS, Moolman-Smook JC, Watkins H.

Cardiovasc Res. 1999 Oct;44(1):20-36. Review.

PMID:
10615387
9.

Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death.

Marian AJ, Roberts R.

J Cardiovasc Electrophysiol. 1998 Jan;9(1):88-99. Review.

PMID:
9475582
10.

Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?

Brito D, Madeira H.

Rev Port Cardiol. 2005 Sep;24(9):1137-46. Review. English, Portuguese.

11.

Familial hypertrophic cardiomyopathy: from mutations to functional defects.

Bonne G, Carrier L, Richard P, Hainque B, Schwartz K.

Circ Res. 1998 Sep 21;83(6):580-93. Review.

12.

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.

Keren A, Syrris P, McKenna WJ.

Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):158-68. doi: 10.1038/ncpcardio1110. Epub 2008 Jan 29. Review. Erratum in: Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):747.

PMID:
18227814
14.

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

Maron BJ, Maron MS, Semsarian C.

J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11. Review.

15.

Molecular and clinical aspects of inherited cardiomyopathies.

Durand JB, Abchee AB, Roberts R.

Ann Med. 1995 Jun;27(3):311-7. Review.

PMID:
7546620
16.

[Clinical and molecular genetics of hypertrophic cardiomyopathy].

Sepp R, Csanády M.

Orv Hetil. 1998 Aug 16;139(33):1965-71. Review. Hungarian.

PMID:
9734214
17.
18.

Molecular genetics of hypertrophic cardiomyopathy.

Marian AJ, Roberts R.

Annu Rev Med. 1995;46:213-22. Review.

PMID:
7598458
19.

[Genetic causes of hypertrophic cardiomyopathy].

Vosberg HP.

Med Klin (Munich). 1998 Apr 15;93(4):252-9. Review. German.

PMID:
9594535
20.

The myosin-activated thin filament regulatory state, M⁻-open: a link to hypertrophic cardiomyopathy (HCM).

Lehrer SS, Geeves MA.

J Muscle Res Cell Motil. 2014 Apr;35(2):153-60. doi: 10.1007/s10974-014-9383-z. Epub 2014 Apr 17. Review.

PMID:
24740688

Supplemental Content

Support Center